Vicarious Surgical Inc (NYSE:RBOT) CEO Adam David Sachs Sells 943 Shares

Vicarious Surgical Inc (NYSE:RBOT) CEO Adam David Sachs sold 943 shares of the business’s stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $14.53, for a total value of $13,701.79. Following the sale, the chief executive officer now directly owns 52,699 shares of the company’s stock, valued at $765,716.47. This represents a 1.76 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Adam David Sachs also recently made the following trade(s):

• On Monday, December 23rd, Adam David Sachs sold 139 shares of Vicarious Surgical stock. The shares were sold at an average price of $12.27, for a total value of $1,705.53.
• On Tuesday, December 3rd, Adam David Sachs sold 463 shares of Vicarious Surgical stock. The shares were sold at an average price of $13.50, for a total value of $6,250.50.

Vicarious Surgical Stock Down 1.6 %

Shares of Vicarious Surgical stock opened at $14.38 on Friday. The stock’s 50-day simple moving average is $13.65 and its 200-day simple moving average is $10.08. Vicarious Surgical Inc has a 52 week low of $4.27 and a 52 week high of $19.00. The company has a market capitalization of $84.96 million, a price-to-earnings ratio of -1.40 and a beta of 1.32.

Wall Street Analyst Weigh In

Separately, Piper Sandler lowered their price objective on Vicarious Surgical from $12.00 to $10.50 and set a “neutral” rating on the stock in a research report on Wednesday, November 13th.

Hedge Funds Weigh In On Vicarious Surgical

Several large investors have recently made changes to their positions in RBOT. DnB Asset Management AS lifted its position in shares of Vicarious Surgical by 21.1% in the fourth quarter. DnB Asset Management AS now owns 21,213 shares of the company’s stock worth $279,000 after buying an additional 3,692 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Vicarious Surgical by 8.2% in the fourth quarter. Geode Capital Management LLC now owns 30,799 shares of the company’s stock worth $405,000 after buying an additional 2,336 shares in the last quarter. Finally, Renaissance Technologies LLC lifted its position in shares of Vicarious Surgical by 11.6% in the fourth quarter. Renaissance Technologies LLC now owns 11,534 shares of the company’s stock worth $152,000 after buying an additional 1,200 shares in the last quarter. 47.27% of the stock is currently owned by hedge funds and other institutional investors.

About Vicarious Surgical

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.